We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.4B
AUM Growth
+$153M
(+0.69%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-4.8%
Top 10 Holdings %
Top 10 Hldgs %
13.8%
Holding
1,474
New
155
Increased
445
Reduced
544
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Conagra Brands
CAG
|
+$72.5M |
| 2 |
ConocoPhillips
COP
|
+$70M |
| 3 |
PepsiCo
PEP
|
+$60.2M |
| 4 |
TJX Companies
TJX
|
+$57.6M |
| 5 |
Dollar General
DG
|
+$57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$122M |
| 2 |
Starbucks
SBUX
|
+$69M |
| 3 |
Altria Group
MO
|
+$64.7M |
| 4 |
RTX Corp
RTX
|
+$63.2M |
| 5 |
UBS Group
UBS
|
+$56.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.92% |
| 2 | Technology | 12.76% |
| 3 | Miscellaneous | 10.7% |
| 4 | Financials | 10.43% |
| 5 | Industrials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Ross Stores
ROST
$73.7B
| $12.3M | 0.05% |
216,900
+16,000
| +8% | +$889K |
|
|
VMRK
327
Vivmark Residential
VMRK
$50.7B
| $12.2M | 0.05% |
177,136
-67,150
| -27% | -$4.62M |
|
328
C.H. Robinson
CHRW
$17.9B
| $12.2M | 0.05% |
+163,900
| New | +$12M |
|
329
Macerich
MAC
$6.41B
| $12.1M | 0.05% |
141,737
+141,100
| +22,151% | +$11M |
|
|
K
330
DELISTED
Kellanova
K
| $12.1M | 0.05% |
157,833
-5,645
| -3% | -$405K |
|
331
Enbridge
ENB
$105B
| $12M | 0.05% |
284,236
+94,279
| +50% | +$3.84M |
|
332
Teva Pharmaceuticals
TEVA
$45.1B
| $11.9M | 0.05% |
237,710
+36,088
| +18% | +$1.92M |
|
|
ICPT
333
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $11.9M | 0.05% |
83,363
-11,101
| -12% | -$1.62M |
|
|
WWAV
334
DELISTED
The WhiteWave Foods Company
WWAV
| $11.9M | 0.05% |
252,524
-5,700
| -2% | -$245K |
|
|
SSRI
335
DELISTED
Silver Standard Resources
SSRI
| $11.8M | 0.05% |
916,279
+20,800
| +2% | +$193K |
|
336
American International
AIG
$39.4B
| $11.8M | 0.05% |
223,550
-5,112
| -2% | -$282K |
|
337
Church & Dwight Co
CHD
$22.3B
| $11.8M | 0.05% |
228,600
-2,200
| -1% | -$106K |
|
|
PGRE
338
DELISTED
Paramount Group
PGRE
| $11.7M | 0.05% |
732,867
+620,713
| +553% | +$10.1M |
|
339
Arrow Electronics
ARW
$10.9B
| $11.6M | 0.05% |
187,920
+64,730
| +53% | +$4.11M |
|
|
EMC
340
DELISTED
EMC CORPORATION
EMC
| $11.6M | 0.05% |
428,095
-145,697
| -25% | -$3.94M |
|
341
Target
TGT
$70.8B
| $11.6M | 0.05% |
166,331
-54,049
| -25% | -$4.03M |
|
342
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $11.5M | 0.05% |
327,485
+13,200
| +4% | +$451K |
|
343
Affiliated Managers Group
AMG
$9.2B
| $11.5M | 0.05% |
81,825
| – | – |
|
344
ManpowerGroup
MAN
$2.7B
| $11.5M | 0.05% |
178,500
+22,700
| +15% | +$1.76M |
|
345
Under Armour Class C
UA
$2.11B
| $11.5M | 0.05% |
+315,119
| New | +$11.6M |
|
|
FRC
346
DELISTED
First Republic Bank
FRC
| $11.4M | 0.05% |
163,307
+151,500
| +1,283% | +$10.5M |
|
347
T. Rowe Price
TROW
$22.6B
| $11.4M | 0.05% |
155,771
+4,200
| +3% | +$313K |
|
348
Avnet
AVT
$8.18B
| $11.3M | 0.05% |
278,560
+4,260
| +2% | +$178K |
|
|
LXFT
349
DELISTED
Luxoft Holding, Inc.
LXFT
| $11.3M | 0.05% |
216,886
+187,386
| +635% | +$10.9M |
|
350
MetLife
MET
$61.7B
| $11.3M | 0.05% |
317,162
+5,212
| +2% | +$203K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2016 Portfolio in Review
As of Q2 2016, Axa held 1,474 positions worth $22.4B, up 0.69% from $22.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa withdrew a net $1.08B in Q2 2016, closing 111 positions and reducing 544 holdings. Its most notable exit was MCGRAW-HILL FINANCIAL INC COM, an estimated $23.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, Axa opened a new position in Willis Towers Watson worth $32.3M.
- Axa's largest Q2 2016 buy was Willis Towers Watson: 260,003 shares worth $32.3M.
- Axa added most to Conagra Brands in Q2 2016, an estimated $72.5M increase.
- Axa's biggest Q2 2016 reduction was St Jude Medical, cutting an estimated $122M.
- Axa fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $23.5M.
- Axa's ten largest holdings make up 14% of its $22.4B portfolio in Q2 2016.
- Axa opened 155 new positions and closed 111 in Q2 2016.
- Axa's portfolio value rose 0.69% quarter-over-quarter to $22.4B.
Based on Axa's 13F filing for Q2 2016, filed 11 Aug 2016.